Purpose of review: Diabetic kidney disease (DKD) is a leading cause of chronic kidney
disease (CKD) for which many treatments exist that have been shown to prevent CKD …

Purpose Emerging evidence has revealed that gut microbiota plays a pivotal role in the
pathogenesis of type 2 diabetes mellitus (T2DM) and diabetic kidney disease (DKD) …

Diabetic kidney disease is a major complication in diabetes mellitus, and the most common
reason for end-stage renal disease. Patients suffering from diabetes mellitus encounter …

Diabetic kidney disease (DKD) is a common complication in patients with diabetes mellitus
(DM). Increasing evidence suggested that the gut microbiota participates in the progression …

Diabetes has become a major global health problem. The elucidation of characteristic
metabolic alterations during the diabetic progression is critical for better understanding its …

Chronic kidney disease (CKD) represents a major challenge to public healthcare.
Traditional clinical biomarkers of renal function (blood urea nitrogen and serum creatinine) …

Background Chronic kidney disease (CKD) is a global public health issue. The diagnosis of
CKD would be considerably enhanced by discovering novel biomarkers used to determine …

Chronic kidney disease (CKD) is a growing burden on people and on healthcare for which
the diagnostics are niether disease-specific nor indicative of progression. Biomarkers are …

The gut microbiota consists of trillions of microorganisms, fulfilling important roles in
metabolism, nutritional intake, physiology and maturation of the immune system, but also …

Type 2 diabetes mellitus (T2DM) has a rising prevalence and diabetic nephropathy (DN) is a
major complication of T2DM. Metabolomics could provide novel insights into the …